Targeting senescent cells cuts post-chemo inflammation
Chemotherapy saves lives but accelerates biological ageing in the body. New research identifies a molecular switch inside senescent cells that drives much of this damage, and shows it can be pharmacologically dialled down.
When cells stop dividing but refuse to die, they enter a state called cellular senescence. These cells release a cocktail of inflammatory molecules known as the SASP (senescence-associated secretory phenotype), which fuels chronic inflammation and contributes to tissue dysfunction. Chemotherapy forces large numbers of cells into this state, amplifying long-term side effects.
The researchers, publishing in Nature Aging, found that CDK4 and CDK6, proteins best known for regulating the cell cycle, also control how inflammatory senescent cells become. They do so through a signalling axis involving the retinoic acid receptor alpha (RARα) and the inflammatory master regulator NF-κB.
Blocking the axis improves function in models
Pharmacologically targeting this CDK4/6–RARα–NF-κB axis reduced the inflammatory output of senescent cells. In animal models, physical function improved both during normal ageing and after chemotherapy-induced tissue damage. These are preclinical results; translation to humans will require further clinical investigation.
CDK4/6 inhibitors are already approved cancer drugs. This finding raises the possibility that they carry an additional, potentially beneficial effect: dampening inflammation from senescent cells. Whether this is clinically meaningful outside of cancer treatment remains an open question.
A different approach to senescent cells
Much research in this field focuses on eliminating senescent cells outright. This study proposes a complementary angle: suppressing their inflammatory output rather than destroying them. From a longevity perspective, the use of an already-approved drug class and measurable functional gains in models is noteworthy, though animal-to-human extrapolation demands caution.
Want to research this yourself?
Search for example:
- CDK4/6 senescence inflammatory phenotype
- NF-κB SASP senescent cells
- chemotherapy-induced ageing physical function